Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How do you approach the management of patients with primary membranous nephropathy and a positive anti-PLA2R antibody test who are being considered for kidney transplantation?
Related Questions
Do you recommend 24 hour urine stone risk studies for patients with no history of nephrolithiasis who are undergoing evaluation as potential kidney donors?
Thoughts about using Fecal transplant as a treatment option for recurrent difficult to treat C diff infection in an elderly kidney transplant patient.
Would you recommend routinely checking ANCA levels just prior to a planned kidney transplantation in patients with a history of ESKD secondary to ANCA-associated vasculitis?
When do you recommend genetic testing prior to kidney transplantation for a patient with ESKD secondary to FSGS?
Would you refer a patient for kidney only or kidney and liver transplantation if they develop advanced chronic kidney disease secondary to primary hyperoxaluria type 2?
How do you approach kidney transplant evaluation and management in an ESKD patient with a history of anti-GBM disease and currently detectable anti-GBM antibodies?
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
When do you use ambulatory blood pressure monitoring to assess hypertension in a living kidney donor candidate?
What is your strategy to manage the complication of long-term immunosuppression in liver transplant recipients, specifically renal dysfunction and onset of cardiometabolic comorbidities?
